8-K: Cross Country Healthcare Reports Q4 and Full Year 2024 Results Amidst Pending Merger with Aya Healthcare

Cross Country Healthcare announced its fourth quarter and full year 2024 financial results, showing revenue declines but highlighting growth in Physician and Homecare Staffing, while awaiting the closing of its merger with Aya Healthcare.

Summary

• Cross Country Healthcare reported a revenue of $309.94 million for Q4 2024, a 25% decrease year-over-year and a 2% decrease sequentially.
• The company's net loss attributable to common stockholders was $3.8 million for Q4 2024, compared to a net income of $9.0 million in the prior year.
• Adjusted EBITDA for Q4 2024 was $9.3 million, or 3.0% of revenue, compared to $20.6 million, or 5.0% of revenue, in the prior year.
• For the full year 2024, consolidated revenue was $1.344 billion, a 33% decrease year-over-year.
• The net loss attributable to common stockholders for the full year was $14.6 million, compared to a net income of $72.6 million in the prior year.
• Adjusted EBITDA for the full year was $49.1 million, or 3.7% of revenue, compared to $144.4 million, or 7.2% of revenue, in the prior year.
• Physician Staffing revenue increased by 13% year-over-year and 5% sequentially in Q4 2024.
• The company repurchased 0.3 million shares of its common stock for $3.6 million during the fourth quarter.
• As of December 31, 2024, Cross Country Healthcare had $81.6 million in cash and cash equivalents with no debt outstanding.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to the significant revenue and profit declines, although the company highlights some positive aspects and is awaiting a potentially positive merger. The lack of forward guidance adds uncertainty.

Positives

• Physician Staffing revenue increased by 13% year-over-year and 5% sequentially in Q4 2024.
• Homecare Staffing experienced sequential and year-over-year revenue growth.
• Cross Country Education experienced double-digit sequential revenue growth.
• The company secured a three-year contract renewal with its largest managed service program.
• Cross Country Healthcare maintains a strong balance sheet with $81.6 million in cash and no debt.
• The company repurchased 0.3 million shares of its common stock for $3.6 million during the fourth quarter.

Negatives

• Q4 2024 revenue decreased by 25% year-over-year to $309.94 million.
• The company reported a net loss of $3.8 million in Q4 2024, compared to a net income of $9.0 million in Q4 2023.
• Adjusted EBITDA for Q4 2024 decreased to $9.3 million from $20.6 million in the prior year.
• Full year 2024 revenue decreased by 33% to $1.344 billion.
• The company reported a net loss of $14.6 million for the full year 2024, compared to a net income of $72.6 million in 2023.
• Consolidated gross profit margin was 20.0% in Q4 2024, down 190 basis points year-over-year.

Risks

• The pending merger with Aya Healthcare is subject to regulatory approval and other closing conditions.
• The company faces risks related to the diversion of management time on transaction-related issues.
• The announcement of the proposed merger could have adverse effects on the market price of the company's common stock.
• The proposed merger could have an adverse effect on the company's ability to retain customers and key personnel.
• The company is exposed to worldwide economic or political changes that affect the markets it serves.
• Global pandemics, epidemics, or other public health crises could impact the company's business.
• Changes in marketplace conditions, such as alternative modes of healthcare delivery, could affect demand for the company's services.

Future Outlook

Due to the pending transaction with Aya Healthcare, the company will not host an earnings conference call or provide forward-looking guidance.

Management Comments

• Our fourth quarter top line performance was driven by continued strength in our non-travel businesses such as Physician Staffing, Education and Homecare, said John A. Martins, President and Chief Executive Officer of Cross Country Healthcare.
• As we await the closing of the pending transaction with Aya Healthcare, which we currently expect to occur in the second half of the year, we continue on our path of delivering clinical excellence in order to meet our clients needs in this dynamic and highly competitive market.

Industry Context

The healthcare staffing industry is highly competitive and dynamic, with evolving client needs and alternative modes of healthcare delivery. The pending merger with Aya Healthcare suggests a move towards consolidation in the industry to gain market share and improve service offerings.

Comparison to Industry Standards

• Without specific competitor data, it's difficult to benchmark precisely, but a 33% revenue decline year-over-year is significant and warrants further investigation compared to industry averages.
• Companies like AMN Healthcare and Team Health are major players, and comparing Cross Country's performance against their results would provide valuable context.
• The adjusted EBITDA margin of 3.7% for the full year is relatively low, suggesting potential challenges in profitability compared to industry leaders.

Stakeholder Impact

• Shareholders are impacted by the decreased financial performance and the pending merger.
• Employees face uncertainty due to the merger and potential restructuring.
• Customers may experience changes in service offerings and pricing due to the merger.
• Suppliers may be affected by changes in procurement strategies post-merger.

Next Steps

• The company will focus on closing the pending transaction with Aya Healthcare.
• Cross Country Healthcare will continue to deliver clinical excellence to meet clients' needs.

Key Dates